Skip to content

Study · Animal study (in vivo) · rat · 2010

1 result

Anticoagulation and antiplatelet effects of semax under conditions of acute and chronic immobilization stress.

Grigorjeva ME, Lyapina LA

Bulletin of experimental biology and medicine1 Jul 2010Cited by 4 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats under acute and chronic immobilization stress, repeated intranasal Semax had a protective antistress effect against hypercoagulation, shown as stimulation of the anticoagulation system.

    In plain wordsIn rats under stress, repeated nasal Semax stimulated the blood anticoagulation system and protected against stress-related clotting.

    Peptide
    Semax
    Outcome
    IncreaseAnticoagulation system activity under immobilization stress
    Study

    ratn: not reported in source

    Acute and chronic immobilization stress (albino rats)
    Outcome group
    Cardiovascular events · Cardiovascular
    Studied dose
    Dose not stated · intranasalAs given in this study (rat).

    Source sentences

    Summary
    Semax exhibited a protective antistress effect after repeated intranasal administration under conditions of hypercoagulation developing in response to immobilization stress of different degree. The effect manifested in stimulation of the anticoagulation system.
    1 context sentence
    Summary · context
    The effects of semax on anticoagulant, fibrinolytic, and platelet components of the anticoagulation system were studied on albino rats under conditions of acute and chronic immobilization stress.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 19:08 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.